Jürgen Wehmeyer

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera

Susanne Schnittger, Ulrike Bacher, Claudia Haferlach et al. · Haematologica · 2009 · 69 citations · Full text

Medicine, Genetics, Hematology +11

Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma—role of radioimmunotherapy

M. Dreyling, Lorenz Trümper, C. von Schilling et al. · Annals of Hematology · 2006 · 35 citations

Medicine, Hematology, Oncology +8

Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia

Ralf Bieker, Christian Lerchenmüller, Jürgen Wehmeyer et al. · Oncology Reports · 2003 · 22 citations

Medicine, Oncology, Pharmacology +13

Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective <scp>QOLIXANE</scp> trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry

Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Alexander Reichart et al. · International Journal of Cancer · 2020 · 21 citations · Full text

Medicine, Oncology, Pharmacology +15

Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study)

Jürgen Wehmeyer, Christoph Losem, Stephan Schmitz et al. · European Journal Of Haematology · 2018 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +17